Skip to content
2000
Volume 17, Issue 2
  • ISSN: 1573-3963
  • E-ISSN: 1875-6336

Abstract

Irritable bowel syndrome (IBS) is one of the most common functional gastro-intestinal disorders which significantly impacts the quality of life of affected children. Abdominal pain improved by defecation, associated with a change in stool form and frequency, represents its specific clinical marker. Even if a number of potential patho-physiological mechanisms have been described, the exact underlying etiology of IBS is so far unclear. Likewise, no optimal treatment has ever been found neither for adult nor for pediatric patients. Current therapeutic options include drugs, dietary interventions and biopsychosocial therapies. The present review aims at evaluating the scientific evidence supporting the efficacy of these treatments for children with IBS.

Loading

Article metrics loading...

/content/journals/cpr/10.2174/1573396317666210127123330
2021-05-01
2025-05-20
Loading full text...

Full text loading...

/content/journals/cpr/10.2174/1573396317666210127123330
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test